Valeant Pharma (VRX) Shares Dip, Recover as Two Sequoia Directors Step Down

Valeant Pharma (NYSE: VRX) shares touched lows, but then ticked higher following news Thursday afternoon that two of five independent directors at Sequoia Fund resigned.

According to the WSJ, Vinod Ahooja and Sharon Osberg will step down from Sequoia's board. Sequoia is Valeant's largest shareholder.

Shares of Valeant dipped lower following headlines with traders assuming two directors of the company resigned. Upon further clarification of the news, the stock bounced back, but is still down around 1.7 percent in afternoon trading.

You May Also Be Interested In

• BlackRock's Tseng to exit as CEO of TCP Private Credit Fund
• SiriusPoint hires Mark Aspinall to lead new fine art & specie unit
• American Vanguard names Hermann Castro as SVP of marketing